Isabella Tsai
About Isabella Tsai
Isabella Tsai serves as the Manager of the R&D Biomedical Laboratory at Acer, where she has worked since 2021. She has a strong background in molecular biology, chemistry, and medical engineering, with previous roles at NovalGen and various prestigious research institutions in the UK.
Work at Acer
Isabella Tsai has been employed at Acer since 2021, serving as the Manager of the R&D Biomedical Laboratory. In this role, she has developed technology platforms within a multidisciplinary environment that integrates molecular biology, chemistry, and medical engineering. Her leadership involves overseeing a team of PhD professionals, focusing on supervision and team building.
Previous Experience in Research
Prior to her current position, Isabella Tsai worked at NovalGen as a Senior Scientist in Discovery from 2019 to 2020 in London, United Kingdom. She also held various postdoctoral roles, including at The Francis Crick Institute from 2014 to 2019, and at University College London from 2012 to 2014. Additionally, she served as a Postdoctoral Scientist at the Medical Research Council for 7 months in 2014 and as a Visiting Scientist at GlaxoSmithKline Pharma GmbH from 2015 to 2016.
Education and Expertise
Isabella Tsai holds a Bachelor of Science (BSc) in Biochemical Science and Technology from National Taiwan University, where she studied from 2000 to 2004. She furthered her education at the University of Cambridge, earning a PhD in Biochemistry from 2007 to 2011. She also obtained a Master of Science (MSc) in Biochemistry and Molecular Biology from National Taiwan University between 2004 and 2006. Her expertise includes the use of bioinformatics tools and software, such as PyMOL, for structural biology research.